ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,420.64
0.01%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Minerva Neurosciences Inc (NERV)

  7. Minerva Neurosciences Inc (NERV) News

NERV Minerva Neurosciences Inc

2.4365
0.0065 (0.27%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Minerva Neurosciences Inc NERV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0065 0.27% 2.4365 06:00:01
Open Price Low Price High Price Close Price Previous Close
2.45 2.43 2.49 2.4365 2.43
more quote information »

Recent News

Date Time Source Heading
28/2/202400:04EDGAR2Form 8-K - Current report
28/2/202400:00GLOBEMinerva Neurosciences Receives Complete Response Letter from..
22/2/202423:00GLOBEMinerva Neurosciences Reports Fourth Quarter and Fiscal Year..
22/2/202422:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/11/202323:30GLOBEMinerva Neurosciences Reports 2023 Third Quarter Financial..
07/11/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/10/202307:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202307:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202306:05EDGAR2Form 8-K - Current report
15/8/202323:28EDGAR2Form ARS - Annual Report to Security Holders
15/8/202323:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/8/202323:25EDGAR2Form DEF 14A - Other definitive proxy statements
10/8/202307:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/8/202322:07EDGAR2Form S-3 - Registration statement under Securities Act of..
01/8/202321:30GLOBEMinerva Neurosciences Reports 2023 Second Quarter Financial..
01/8/202321:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/7/202306:18EDGAR2Form SC 13D - General statement of acquisition of beneficial..
28/6/202322:37EDGAR2Form 8-K - Current report
28/6/202322:30GLOBEMinerva Neurosciences Announces $20 Million in Private..
15/5/202321:30GLOBEMinerva Neurosciences Reports 2023 First Quarter Financial..
10/5/202322:00GLOBEMinerva Neurosciences Announces Update on its New Drug..
08/5/202322:30GLOBEMinerva Neurosciences to Report First Quarter 2023 Financial..
01/5/202321:00GLOBEMinerva Neurosciences Announces the NDA Filing for..

Your Recent History

NASDAQ
NERV
Minerva Neurosciences
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved